Market Overview

Spark Therapeutics, Pfizer Publish Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B In NE Journal of Medicine

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Biotech

 

Related Articles (PFE + ONCE)